Skip to main content

Published locations for Adding ipilimumab to nivolumab provides no benefit in SCC trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding ipilimumab to nivolumab provides no benefit in SCC trial

User login

  • Reset your password
  • /content/adding-ipilimumab-nivolumab-provides-no-benefit-scc-trial
  • /fedprac/article/202793/lung-cancer/adding-ipilimumab-nivolumab-provides-no-benefit-scc-trial
  • /oncologypractice/article/202793/lung-cancer/adding-ipilimumab-nivolumab-provides-no-benefit-scc
  • /fedprac/avaho/article/202793/lung-cancer/adding-ipilimumab-nivolumab-provides-no-benefit-scc-trial
  • /hematology-oncology/article/202793/lung-cancer/adding-ipilimumab-nivolumab-provides-no-benefit-scc
  • /chestphysician/article/202793/lung-cancer/adding-ipilimumab-nivolumab-provides-no-benefit-scc-trial